137 results
Page 6 of 7
424B5
1jaz y5mmwi8
2 Nov 18
Prospectus supplement for primary offering
6:13am
8-K
EX-10.1
b5d6t508k4s
31 Oct 18
Entry into a Material Definitive Agreement
9:20am
8-K/A
EX-99.1
djjhqwt94qglk8dq
11 Oct 18
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
8:15pm
8-K/A
54hjjg2yuy 7b
11 Oct 18
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
8:15pm
8-K
EX-99.1
5ps iz9dkhq
11 Oct 18
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
4:30pm
8-K
yfx zo7mge4p9u5mz2y
11 Oct 18
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
4:30pm
8-K
kwhyj y5kz2
19 Jun 18
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:20pm
8-K
mkt5lk
31 May 18
Akers Biosciences Granted 180-Day Extension by Nasdaq
8:21am
8-K
EX-99.1
9w53oswgis nxv
31 May 18
Akers Biosciences Granted 180-Day Extension by Nasdaq
8:21am
8-K
EX-3.1
pmnxfmn f365c
26 Dec 17
Akers Biosciences Announces Closing of $6,900,000 Public Offering
12:00am
424B4
956s q7y4p
20 Dec 17
Prospectus supplement with pricing info
12:00am